达雷妥尤单抗用于HLA配型不合的异基因干细胞移植病例中供者特异性抗HLA抗体脱敏治疗 - Suppr

Suppr

超能文献

Daratumumab for donor-specific anti-HLA antibody desensitization in a case of HLA-mismatched allogeneic stem cell transplantation.

作者信息

Ibrahim Uroosa, Keyzner Alla

机构信息

Bone Marrow Transplant and Cellular Therapy, Tisch Cancer Institute, The Mount Sinai Hospital, New York, NY, USA.

出版信息

Hematol Transfus Cell Ther. 2023 Oct-Dec;45(4):510-512. doi: 10.1016/j.htct.2021.11.019. Epub 2022 Jan 25.

DOI:10.1016/j.htct.2021.11.019

PMID:35105529

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10627859/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dc2/10627859/fe81cef9b7cc/gr1.jpg

相似文献

Daratumumab for donor-specific anti-HLA antibody desensitization in a case of HLA-mismatched allogeneic stem cell transplantation.

Hematol Transfus Cell Ther. 2023 Oct-Dec;45(4):510-512. doi: 10.1016/j.htct.2021.11.019. Epub 2022 Jan 25.

Effective desensitization for a strong donor-specific HLA antibody in a case of HLA-mismatched allogeneic hematopoietic cell transplantation.

HLA. 2019 Sep;94(3):307-311. doi: 10.1111/tan.13627. Epub 2019 Aug 6.

Daratumumab in Sensitized Kidney Transplantation: Potentials and Limitations of Experimental and Clinical Use.

J Am Soc Nephrol. 2019 Jul;30(7):1206-1219. doi: 10.1681/ASN.2018121254. Epub 2019 Jun 21.

Evolution of HLA testing for hematopoietic stem cell transplantation: Importance of the candidate's antibody profile for donor selection.

Hum Immunol. 2022 Oct;83(10):721-729. doi: 10.1016/j.humimm.2022.04.012. Epub 2022 May 5.

The Role of HLA Antibodies in HLA Mismatched Allogeneic Hematopoietic Stem Cell Transplantation.

Clin Transpl. 2014:245-50.

Effective desensitization of donor-specific HLA antibodies using platelet transfusion bearing targeted HLA in a case of HLA-mismatched allogeneic stem cell transplantation.

Bone Marrow Transplant. 2017 May;52(5):794-796. doi: 10.1038/bmt.2017.10. Epub 2017 Feb 6.

A Case of Daratumumab-Induced Significant Decrease in Donor-Specific HLA Antibodies and Remission Induction Before Haploidentical Stem Cell Transplantation in a Refractory B-ALL Patient.

Cell Transplant. 2022 Jan-Dec;31:9636897221132502. doi: 10.1177/09636897221132502.

Pure Red Cell Aplasia following ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation: Resolution with Daratumumab Treatment.

Acta Haematol. 2021;144(6):683-687. doi: 10.1159/000515257. Epub 2021 Apr 22.

Successful treatment of refractory red cell aplasia after allogeneic hematopoietic cell transplantation with daratumumab.

Eur J Haematol. 2020 Feb;104(2):145-147. doi: 10.1111/ejh.13343. Epub 2019 Nov 20.

The allogeneic HLA-DP-restricted T-cell repertoire provoked by allogeneic dendritic cells contains T cells that show restricted recognition of hematopoietic cells including primary malignant cells.

Haematologica. 2019 Jan;104(1):197-206. doi: 10.3324/haematol.2018.193680. Epub 2018 Sep 20.

引用本文的文献

Daratumumab for De-sensitization of Donor Specific Antibodies: Is it a Quicker and Easier way?

Indian J Hematol Blood Transfus. 2024 Jul;40(3):508-510. doi: 10.1007/s12288-023-01712-8. Epub 2023 Nov 24.

Desensitization Strategies for Donor-Specific Antibodies in HLA-Mismatched Stem Cell Transplantation Recipients: What We Know and What We Do Not Know.

Oncol Ther. 2024 Sep;12(3):375-394. doi: 10.1007/s40487-024-00283-6. Epub 2024 Jun 15.

Acute mixed-lineage leukemia treated with desensitization therapy prior to HLA-haploidentical transplantation with high donor-specific antibodies.

Int J Hematol. 2024 Aug;120(2):256-261. doi: 10.1007/s12185-024-03775-3. Epub 2024 Apr 27.

Donor-specific antibody desensitization with daratumumab prior to haematopoietic cell transplant for sickle cell disease: A case report.

Br J Haematol. 2024 Apr;204(4):1540-1544. doi: 10.1111/bjh.19289. Epub 2024 Jan 11.

本文引用的文献

Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibody.

Bone Marrow Transplant. 2020 Jul;55(7):1326-1336. doi: 10.1038/s41409-020-0928-z. Epub 2020 May 8.

Daratumumab in Sensitized Kidney Transplantation: Potentials and Limitations of Experimental and Clinical Use.

J Am Soc Nephrol. 2019 Jul;30(7):1206-1219. doi: 10.1681/ASN.2018121254. Epub 2019 Jun 21.

A strategy to reduce donor-specific HLA Abs before allogeneic transplantation.

Bone Marrow Transplant. 2014 May;49(5):722-4. doi: 10.1038/bmt.2014.11. Epub 2014 Feb 17.

Partially mismatched transplantation and human leukocyte antigen donor-specific antibodies.

Biol Blood Marrow Transplant. 2013 Apr;19(4):647-52. doi: 10.1016/j.bbmt.2013.01.016. Epub 2013 Jan 22.

Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation.

Blood. 2011 Nov 24;118(22):5957-64. doi: 10.1182/blood-2011-06-362111. Epub 2011 Oct 3.

Immune modulation to prevent antibody-mediated rejection after allogeneic hematopoietic stem cell transplantation.

Transpl Immunol. 2011 Sep;25(2-3):153-8. doi: 10.1016/j.trim.2011.06.001. Epub 2011 Jun 21.

High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation.

Transplantation. 2009 Oct 27;88(8):1019-24. doi: 10.1097/TP.0b013e3181b9d710.

Successful engraftment in crossmatch-positive HLA-mismatched peripheral blood stem cell transplantation after depletion of antidonor cytotoxic HLA antibodies with rituximab and donor platelet infusion.

Bone Marrow Transplant. 2005 Sep;36(6):555-6. doi: 10.1038/sj.bmt.1705070.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验